3 results
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
offer to our executive officers, individually as well as in the aggregate, is competitive and aligned with our business and executive talent
8-K
EX-99.1
CADL
Candel Therapeutics Inc
29 Mar 22
Candel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights
8:32am
key clinical trial accrual milestones and by enhancing our talent pool,” said Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer
- Prev
- 1
- Next